Sinonasal Teratocarcinosarcoma

K. Kenneth Chao; Tony Y. Eng; Jonathan Barnes; Rajiv Dahiya

doi:10.1097/01.coc.0000045851.76922.2E

Sinonasal Teratocarcinosarcoma

K. Kenneth Chao, Tony Y. Eng, Jonathan Barnes, Rajiv Dahiya

Radiation Oncology

Research output: Contribution to journal › Article

24 Scopus citations

Abstract

Sinonasal teratocarcinosarcoma (SNTCS) is a distinctly rare tumor characterized by a variegated histologic architecture of epithelial and mesenchymal components. By reported accounts, SNTCS is a highly malignant tumor displaying rapid, aggressive growth. Prognosis is poor: less than 45% of all patients survive past 5 years. Combination surgery and radiotherapy currently appear to be the most effective treatment. This report presents a 76-year-old African American man with a SNTCS in the right nasal cavity and paranasal sinuses. The patient was treated with combination surgical excision and postoperative radiation therapy. The clinical and pathologic features and clinical course will be discussed.

Original language	English (US)
Pages (from-to)	29-32
Number of pages	4
Journal	American Journal of Clinical Oncology: Cancer Clinical Trials
Volume	27
Issue number	1
DOIs	https://doi.org/10.1097/01.coc.0000045851.76922.2E
Publication status	Published - Feb 1 2004

Fingerprint

Keywords

Radiation therapy
Sinonasal teratocarcinosarcoma

ASJC Scopus subject areas

Oncology
Cancer Research

Cite this

Chao, K. K., Eng, T. Y., Barnes, J., & Dahiya, R. (2004). Sinonasal Teratocarcinosarcoma. American Journal of Clinical Oncology: Cancer Clinical Trials, 27(1), 29-32. https://doi.org/10.1097/01.coc.0000045851.76922.2E

@article{d3063898f7174e0997a5dd41baefa78d,

title = "Sinonasal Teratocarcinosarcoma",

abstract = "Sinonasal teratocarcinosarcoma (SNTCS) is a distinctly rare tumor characterized by a variegated histologic architecture of epithelial and mesenchymal components. By reported accounts, SNTCS is a highly malignant tumor displaying rapid, aggressive growth. Prognosis is poor: less than 45{\%} of all patients survive past 5 years. Combination surgery and radiotherapy currently appear to be the most effective treatment. This report presents a 76-year-old African American man with a SNTCS in the right nasal cavity and paranasal sinuses. The patient was treated with combination surgical excision and postoperative radiation therapy. The clinical and pathologic features and clinical course will be discussed.",

keywords = "Radiation therapy, Sinonasal teratocarcinosarcoma",

author = "Chao, {K. Kenneth} and Eng, {Tony Y.} and Jonathan Barnes and Rajiv Dahiya",

year = "2004",

month = "2",

day = "1",

doi = "10.1097/01.coc.0000045851.76922.2E",

language = "English (US)",

volume = "27",

pages = "29--32",

journal = "American Journal of Clinical Oncology",

issn = "0277-3732",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Sinonasal Teratocarcinosarcoma

AU - Chao, K. Kenneth

AU - Eng, Tony Y.

AU - Barnes, Jonathan

AU - Dahiya, Rajiv

PY - 2004/2/1

Y1 - 2004/2/1

N2 - Sinonasal teratocarcinosarcoma (SNTCS) is a distinctly rare tumor characterized by a variegated histologic architecture of epithelial and mesenchymal components. By reported accounts, SNTCS is a highly malignant tumor displaying rapid, aggressive growth. Prognosis is poor: less than 45% of all patients survive past 5 years. Combination surgery and radiotherapy currently appear to be the most effective treatment. This report presents a 76-year-old African American man with a SNTCS in the right nasal cavity and paranasal sinuses. The patient was treated with combination surgical excision and postoperative radiation therapy. The clinical and pathologic features and clinical course will be discussed.

AB - Sinonasal teratocarcinosarcoma (SNTCS) is a distinctly rare tumor characterized by a variegated histologic architecture of epithelial and mesenchymal components. By reported accounts, SNTCS is a highly malignant tumor displaying rapid, aggressive growth. Prognosis is poor: less than 45% of all patients survive past 5 years. Combination surgery and radiotherapy currently appear to be the most effective treatment. This report presents a 76-year-old African American man with a SNTCS in the right nasal cavity and paranasal sinuses. The patient was treated with combination surgical excision and postoperative radiation therapy. The clinical and pathologic features and clinical course will be discussed.

KW - Radiation therapy

KW - Sinonasal teratocarcinosarcoma

UR - http://www.scopus.com/inward/record.url?scp=0842305820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0842305820&partnerID=8YFLogxK

U2 - 10.1097/01.coc.0000045851.76922.2E

DO - 10.1097/01.coc.0000045851.76922.2E

M3 - Article

C2 - 14758130

AN - SCOPUS:0842305820

VL - 27

SP - 29

EP - 32

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 1

ER -

Access to Document

10.1097/01.coc.0000045851.76922.2E